Human Chorionic Gonadotropin Market

ID: MRFR/HC/28926-HCR 100 Pages Rahul Gotadki Last Updated: November 16, 2026
Human Chorionic Gonadotropin Market Research Report By Application (Infertility Treatment, Ovulation Induction, Pregnancy Testing, Other Applications), By Source (Urine, Serum), By Form (Injectable, Oral, Nasal Spray), By Manufacturing Process (Extraction from Urine, Recombinant DNA Technology), By End User (Hospitals, Clinics, Diagnostic Laboratories, Individuals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
Human Chorionic Gonadotropin Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)3.17%
2024 Market Size$ 2.17 Billion
2025 Market Size$ 2.24 Billion
2035 Market Size$ 3.07 Billion
Key Players
Ferring Pharmaceuticals
Merck KGaA
IBSA Farmaceutici Italia
HCG Solutions
HCG Clinic
Scripps Laboratories
Opportunities
  • Rising Incidence of Hormonal Disorders
  • Increasing Awareness of Fertility Issues
  • Growing Investment in Research and Development
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Application (USD Billion) | |
      1. 4.1.1 Infertility Treatment | |
      2. 4.1.2 Ovulation Induction | |
      3. 4.1.3 Pregnancy Testing | |
      4. 4.1.4 Other Applications |
    2. 4.2 Healthcare, BY Source (USD Billion) | |
      1. 4.2.1 Urine | |
      2. 4.2.2 Serum |
    3. 4.3 Healthcare, BY Form (USD Billion) | |
      1. 4.3.1 Injectable | |
      2. 4.3.2 Oral | |
      3. 4.3.3 Nasal Spray |
    4. 4.4 Healthcare, BY Manufacturing Process (USD Billion) | |
      1. 4.4.1 Extraction from Urine | |
      2. 4.4.2 Recombinant DNA Technology |
    5. 4.5 Healthcare, BY End User (USD Billion) | |
      1. 4.5.1 Hospitals | |
      2. 4.5.2 Clinics | |
      3. 4.5.3 Diagnostic Laboratories | |
      4. 4.5.4 Individuals |
    6. 4.6 Healthcare, BY Region (USD Billion) | |
      1. 4.6.1 North America | | |
        1. 4.6.1.1 US | | |
        2. 4.6.1.2 Canada | |
      2. 4.6.2 Europe | | |
        1. 4.6.2.1 Germany | | |
        2. 4.6.2.2 UK | | |
        3. 4.6.2.3 France | | |
        4. 4.6.2.4 Russia | | |
        5. 4.6.2.5 Italy | | |
        6. 4.6.2.6 Spain | | |
        7. 4.6.2.7 Rest of Europe | |
      3. 4.6.3 APAC | | |
        1. 4.6.3.1 China | | |
        2. 4.6.3.2 India | | |
        3. 4.6.3.3 Japan | | |
        4. 4.6.3.4 South Korea | | |
        5. 4.6.3.5 Malaysia | | |
        6. 4.6.3.6 Thailand | | |
        7. 4.6.3.7 Indonesia | | |
        8. 4.6.3.8 Rest of APAC | |
      4. 4.6.4 South America | | |
        1. 4.6.4.1 Brazil | | |
        2. 4.6.4.2 Mexico | | |
        3. 4.6.4.3 Argentina | | |
        4. 4.6.4.4 Rest of South America | |
      5. 4.6.5 MEA | | |
        1. 4.6.5.1 GCC Countries | | |
        2. 4.6.5.2 South Africa | | |
        3. 4.6.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Ferring Pharmaceuticals (CH) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Merck KGaA (DE) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 IBSA Farmaceutici Italia (IT) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 HCG Solutions (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 HCG Clinic (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Scripps Laboratories (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Bharat Serums and Vaccines (IN) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Zydus Cadila (IN) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY APPLICATION |
    7. 6.4 US MARKET ANALYSIS BY SOURCE |
    8. 6.5 US MARKET ANALYSIS BY FORM |
    9. 6.6 US MARKET ANALYSIS BY MANUFACTURING PROCESS |
    10. 6.7 US MARKET ANALYSIS BY END USER |
    11. 6.8 CANADA MARKET ANALYSIS BY APPLICATION |
    12. 6.9 CANADA MARKET ANALYSIS BY SOURCE |
    13. 6.10 CANADA MARKET ANALYSIS BY FORM |
    14. 6.11 CANADA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    15. 6.12 CANADA MARKET ANALYSIS BY END USER |
    16. 6.13 EUROPE MARKET ANALYSIS |
    17. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION |
    18. 6.15 GERMANY MARKET ANALYSIS BY SOURCE |
    19. 6.16 GERMANY MARKET ANALYSIS BY FORM |
    20. 6.17 GERMANY MARKET ANALYSIS BY MANUFACTURING PROCESS |
    21. 6.18 GERMANY MARKET ANALYSIS BY END USER |
    22. 6.19 UK MARKET ANALYSIS BY APPLICATION |
    23. 6.20 UK MARKET ANALYSIS BY SOURCE |
    24. 6.21 UK MARKET ANALYSIS BY FORM |
    25. 6.22 UK MARKET ANALYSIS BY MANUFACTURING PROCESS |
    26. 6.23 UK MARKET ANALYSIS BY END USER |
    27. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION |
    28. 6.25 FRANCE MARKET ANALYSIS BY SOURCE |
    29. 6.26 FRANCE MARKET ANALYSIS BY FORM |
    30. 6.27 FRANCE MARKET ANALYSIS BY MANUFACTURING PROCESS |
    31. 6.28 FRANCE MARKET ANALYSIS BY END USER |
    32. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION |
    33. 6.30 RUSSIA MARKET ANALYSIS BY SOURCE |
    34. 6.31 RUSSIA MARKET ANALYSIS BY FORM |
    35. 6.32 RUSSIA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    36. 6.33 RUSSIA MARKET ANALYSIS BY END USER |
    37. 6.34 ITALY MARKET ANALYSIS BY APPLICATION |
    38. 6.35 ITALY MARKET ANALYSIS BY SOURCE |
    39. 6.36 ITALY MARKET ANALYSIS BY FORM |
    40. 6.37 ITALY MARKET ANALYSIS BY MANUFACTURING PROCESS |
    41. 6.38 ITALY MARKET ANALYSIS BY END USER |
    42. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION |
    43. 6.40 SPAIN MARKET ANALYSIS BY SOURCE |
    44. 6.41 SPAIN MARKET ANALYSIS BY FORM |
    45. 6.42 SPAIN MARKET ANALYSIS BY MANUFACTURING PROCESS |
    46. 6.43 SPAIN MARKET ANALYSIS BY END USER |
    47. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    48. 6.45 REST OF EUROPE MARKET ANALYSIS BY SOURCE |
    49. 6.46 REST OF EUROPE MARKET ANALYSIS BY FORM |
    50. 6.47 REST OF EUROPE MARKET ANALYSIS BY MANUFACTURING PROCESS |
    51. 6.48 REST OF EUROPE MARKET ANALYSIS BY END USER |
    52. 6.49 APAC MARKET ANALYSIS |
    53. 6.50 CHINA MARKET ANALYSIS BY APPLICATION |
    54. 6.51 CHINA MARKET ANALYSIS BY SOURCE |
    55. 6.52 CHINA MARKET ANALYSIS BY FORM |
    56. 6.53 CHINA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    57. 6.54 CHINA MARKET ANALYSIS BY END USER |
    58. 6.55 INDIA MARKET ANALYSIS BY APPLICATION |
    59. 6.56 INDIA MARKET ANALYSIS BY SOURCE |
    60. 6.57 INDIA MARKET ANALYSIS BY FORM |
    61. 6.58 INDIA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    62. 6.59 INDIA MARKET ANALYSIS BY END USER |
    63. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION |
    64. 6.61 JAPAN MARKET ANALYSIS BY SOURCE |
    65. 6.62 JAPAN MARKET ANALYSIS BY FORM |
    66. 6.63 JAPAN MARKET ANALYSIS BY MANUFACTURING PROCESS |
    67. 6.64 JAPAN MARKET ANALYSIS BY END USER |
    68. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    69. 6.66 SOUTH KOREA MARKET ANALYSIS BY SOURCE |
    70. 6.67 SOUTH KOREA MARKET ANALYSIS BY FORM |
    71. 6.68 SOUTH KOREA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    72. 6.69 SOUTH KOREA MARKET ANALYSIS BY END USER |
    73. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    74. 6.71 MALAYSIA MARKET ANALYSIS BY SOURCE |
    75. 6.72 MALAYSIA MARKET ANALYSIS BY FORM |
    76. 6.73 MALAYSIA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    77. 6.74 MALAYSIA MARKET ANALYSIS BY END USER |
    78. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION |
    79. 6.76 THAILAND MARKET ANALYSIS BY SOURCE |
    80. 6.77 THAILAND MARKET ANALYSIS BY FORM |
    81. 6.78 THAILAND MARKET ANALYSIS BY MANUFACTURING PROCESS |
    82. 6.79 THAILAND MARKET ANALYSIS BY END USER |
    83. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION |
    84. 6.81 INDONESIA MARKET ANALYSIS BY SOURCE |
    85. 6.82 INDONESIA MARKET ANALYSIS BY FORM |
    86. 6.83 INDONESIA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    87. 6.84 INDONESIA MARKET ANALYSIS BY END USER |
    88. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    89. 6.86 REST OF APAC MARKET ANALYSIS BY SOURCE |
    90. 6.87 REST OF APAC MARKET ANALYSIS BY FORM |
    91. 6.88 REST OF APAC MARKET ANALYSIS BY MANUFACTURING PROCESS |
    92. 6.89 REST OF APAC MARKET ANALYSIS BY END USER |
    93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
    94. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION |
    95. 6.92 BRAZIL MARKET ANALYSIS BY SOURCE |
    96. 6.93 BRAZIL MARKET ANALYSIS BY FORM |
    97. 6.94 BRAZIL MARKET ANALYSIS BY MANUFACTURING PROCESS |
    98. 6.95 BRAZIL MARKET ANALYSIS BY END USER |
    99. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION |
    100. 6.97 MEXICO MARKET ANALYSIS BY SOURCE |
    101. 6.98 MEXICO MARKET ANALYSIS BY FORM |
    102. 6.99 MEXICO MARKET ANALYSIS BY MANUFACTURING PROCESS |
    103. 6.100 MEXICO MARKET ANALYSIS BY END USER |
    104. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    105. 6.102 ARGENTINA MARKET ANALYSIS BY SOURCE |
    106. 6.103 ARGENTINA MARKET ANALYSIS BY FORM |
    107. 6.104 ARGENTINA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    108. 6.105 ARGENTINA MARKET ANALYSIS BY END USER |
    109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY SOURCE |
    111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORM |
    112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
    114. 6.111 MEA MARKET ANALYSIS |
    115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY SOURCE |
    117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY FORM |
    118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY MANUFACTURING PROCESS |
    119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY END USER |
    120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY SOURCE |
    122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY FORM |
    123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY END USER |
    125. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    126. 6.123 REST OF MEA MARKET ANALYSIS BY SOURCE |
    127. 6.124 REST OF MEA MARKET ANALYSIS BY FORM |
    128. 6.125 REST OF MEA MARKET ANALYSIS BY MANUFACTURING PROCESS |
    129. 6.126 REST OF MEA MARKET ANALYSIS BY END USER |
    130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
    131. 6.128 RESEARCH PROCESS OF MRFR |
    132. 6.129 DRO ANALYSIS OF HEALTHCARE |
    133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
    136. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    137. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    138. 6.135 HEALTHCARE, BY SOURCE, 2024 (% SHARE) |
    139. 6.136 HEALTHCARE, BY SOURCE, 2024 TO 2035 (USD Billion) |
    140. 6.137 HEALTHCARE, BY FORM, 2024 (% SHARE) |
    141. 6.138 HEALTHCARE, BY FORM, 2024 TO 2035 (USD Billion) |
    142. 6.139 HEALTHCARE, BY MANUFACTURING PROCESS, 2024 (% SHARE) |
    143. 6.140 HEALTHCARE, BY MANUFACTURING PROCESS, 2024 TO 2035 (USD Billion) |
    144. 6.141 HEALTHCARE, BY END USER, 2024 (% SHARE) |
    145. 6.142 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
    146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    147. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.2.5 BY END USER, 2025-2035 (USD Billion) |
    149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.3.5 BY END USER, 2025-2035 (USD Billion) |
    150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.4.5 BY END USER, 2025-2035 (USD Billion) |
    151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.5.5 BY END USER, 2025-2035 (USD Billion) |
    152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.6.5 BY END USER, 2025-2035 (USD Billion) |
    153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.7.5 BY END USER, 2025-2035 (USD Billion) |
    154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.8.5 BY END USER, 2025-2035 (USD Billion) |
    155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.9.5 BY END USER, 2025-2035 (USD Billion) |
    156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.10.5 BY END USER, 2025-2035 (USD Billion) |
    157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.11.5 BY END USER, 2025-2035 (USD Billion) |
    158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.12.5 BY END USER, 2025-2035 (USD Billion) |
    159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.13.5 BY END USER, 2025-2035 (USD Billion) |
    160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.14.5 BY END USER, 2025-2035 (USD Billion) |
    161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.15.5 BY END USER, 2025-2035 (USD Billion) |
    162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.16.5 BY END USER, 2025-2035 (USD Billion) |
    163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.17.5 BY END USER, 2025-2035 (USD Billion) |
    164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.18.5 BY END USER, 2025-2035 (USD Billion) |
    165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.19.5 BY END USER, 2025-2035 (USD Billion) |
    166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.20.5 BY END USER, 2025-2035 (USD Billion) |
    167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.21.5 BY END USER, 2025-2035 (USD Billion) |
    168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.22.5 BY END USER, 2025-2035 (USD Billion) |
    169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.23.5 BY END USER, 2025-2035 (USD Billion) |
    170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.24.5 BY END USER, 2025-2035 (USD Billion) |
    171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.25.5 BY END USER, 2025-2035 (USD Billion) |
    172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.26.5 BY END USER, 2025-2035 (USD Billion) |
    173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.27.5 BY END USER, 2025-2035 (USD Billion) |
    174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.28.5 BY END USER, 2025-2035 (USD Billion) |
    175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.29.5 BY END USER, 2025-2035 (USD Billion) |
    176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY APPLICATION, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY SOURCE, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY FORM, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY MANUFACTURING PROCESS, 2025-2035 (USD Billion) | |
      5. 7.30.5 BY END USER, 2025-2035 (USD Billion) |
    177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    178. 7.32 ACQUISITION/PARTNERSHIP | |

Human Chorionic Gonadotropin Market Segmentation

Human Chorionic Gonadotropin Market By Application (USD Billion, 2025-2035)

  • Infertility Treatment
  • Ovulation Induction
  • Pregnancy Testing
  • Other Applications

Human Chorionic Gonadotropin Market By Source (USD Billion, 2025-2035)

  • Urine
  • Serum

Human Chorionic Gonadotropin Market By Form (USD Billion, 2025-2035)

  • Injectable
  • Oral
  • Nasal Spray

Human Chorionic Gonadotropin Market By Manufacturing Process (USD Billion, 2025-2035)

  • Extraction from Urine
  • Recombinant DNA Human Chorionic Gonadotropin Market

Human Chorionic Gonadotropin Market By End User (USD Billion, 2025-2035)

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Individuals
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.